Table 3.
Characteristics | Levels | HR (95% CI for HR) | P-value |
---|---|---|---|
Sex | Female | 2.7(1.024, 6.987) | 0.0445* |
Male | 1.0 | - | |
Age | >20 | 0.9(0.324, 2.626) | 0.8789 |
≤ 20 | 1.0 | - | |
Stage | Localized | 0.7(0.188, 2.263) | 0.5012 |
Regional extension | 0.9(0.242, 3.048) | 0.8144 | |
Distant metastasis | 1.0 | - | |
AKT-Expression | High | 3.0(0.955, 9.499) | 0.0459 |
Negative/Low | 1.0 | - | |
mTOR-Expression | High | 1.4(0.405, 5.163) | 0.5695 |
Negative/Low | 1.0 | - | |
ERK-Expression | High | 2.3(0.713, 7.650) | 0.1609 |
Negative/Low | 1.0 | - | |
YAP-Expression | High | 0.9(0.295, 2.916) | 0.8969 |
Negative/Low | 1.0 | - |
*Chi-square test significant at α=0.05.